Get the Stockscreener App
6.47
2.00%
-0.02
Xbiotech Inc stock is traded at $6.47, with a volume of 2,468.
It is down -2.00% in the last 24 hours and down -15.98% over the past month.
XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. It is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-IL-1 a therapeutic antibody as a treatment for cancer. Geographically, all of its operations are in the United States.
See More
Previous Close:
$6.49
Open:
$6.55
24h Volume:
2,468
Relative Volume:
0.05
Market Cap:
$197.84M
Revenue:
$4.01M
Net Income/Loss:
$-35.01M
P/E Ratio:
-6.883
EPS:
-0.94
Net Cash Flow:
$-24.53M
1W Performance:
-8.75%
1M Performance:
-15.98%
6M Performance:
-27.23%
1Y Performance:
+78.65%
1-Day Range:
$6.47
$6.67
1-Week Range:
$6.36
$7.17
52-Week Range:
$3.51
$9.96
Xbiotech Inc Stock (XBIT) Company Profile
Name
Xbiotech Inc
Sector
Industry
Phone
512-386-2900
Address
5217 WINNEBAGO LANE, AUSTIN, TX
Compare XBIT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
| XBIT | 6.47 | 197.84M | 4.01M | -35.01M | -24.53M | -0.94 |
| VRTX | 447.95 | 115.74B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 741.90 | 81.65B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 589.67 | 34.86B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 249.68 | 32.09B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 102.56 | 24.49B | 3.30B | -501.07M | 1.03B | 11.54 |
Xbiotech Inc Stock (XBIT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-14-19 | Initiated | Piper Jaffray | Overweight |
| Apr-21-17 | Downgrade | Noble Financial | Buy → Hold |
| Jun-28-16 | Reiterated | Noble Financial | Buy |
Xbiotech Inc Stock (XBIT) Latest News
XBiotech (NASDAQ:XBIT) Stock Price Passes Below 50-Day Moving AverageHere's Why - MarketBeat
Cancer Cachexia Market Demand, Segments, And Growth to 2033 Helsinn, Aphios, Eli Lilly, XBiotech - openPR
How To Trade (XBIT) - Stock Traders Daily
XBiotech: Q3 Earnings Snapshot - New Haven Register
Transforming lives for those battling cancer with the speed & precision of AIRakovina Therapeutics (TSXV: RKV) | GCFF - NAI 500
XBiotech (NASDAQ:XBIT) Stock Passes Above 50-Day Moving AverageTime to Sell? - MarketBeat
XBiotech Inc.'s (NASDAQ:XBIT) 12% gain last week benefited both individual investors who own 49% as well as insiders - Simply Wall St
(XBIT) Technical Data - Stock Traders Daily
XBiotech (NASDAQ:XBIT) Share Price Passes Above 50-Day Moving AverageWhat's Next? - MarketBeat
(XBIT) Technical Pivots with Risk Controls - Stock Traders Daily
Desmoplastic Small Round Cell Tumor Treatment Market Overall - openPR
XBiotech (NASDAQ:XBIT) Stock Passes Above 50 Day Moving AverageShould You Sell? - MarketBeat
How the (XBIT) price action is used to our Advantage - Stock Traders Daily
Enerflex Ltd. (NYSE:EFXT) Stake Increased by The Manufacturers Life Insurance Company - Defense World
Alopecia Areata Market Analysis, Size, Market Report 2024-2033 - WhaTech
76,460 Shares in XBiotech Inc. (NASDAQ:XBIT) Acquired by American Century Companies Inc. - Defense World
American Century Companies Inc. Acquires Shares of 76,460 XBiotech Inc. (NASDAQ:XBIT) - MarketBeat
Cancer Antigen Market Size Is Booming Worldwide with Share, Size, Top Key Players - Talented India
Rhumbline Advisers Has $103,000 Stock Holdings in XBiotech Inc. (NASDAQ:XBIT) - Defense World
Rhumbline Advisers Has $335,000 Stock Position in The First of Long Island Co. (NASDAQ:FLIC) - Defense World
Bank of New York Mellon Corp Buys 49,863 Shares of XBiotech Inc. (NASDAQ:XBIT) - Defense World
XBiotech (NASDAQ:XBIT) vs. Harmony Biosciences (NASDAQ:HRMY) Financial Contrast - Defense World
XBiotech (NASDAQ:XBIT) Shares Pass Above 50 Day Moving Average of $6.63 - Defense World
XBiotech (NASDAQ:XBIT) Stock Price Passes Above 50-Day Moving Average of $6.63 - MarketBeat
Objective long/short (XBIT) Report - Stock Traders Daily
XBiotech (NASDAQ:XBIT) Shares Pass Above 50-Day Moving Average of $6.47 - MarketBeat
XBiotech (NASDAQ:XBIT) Stock Crosses Above Fifty Day Moving Average of $6.47 - Defense World
Is XBiotech (NASDAQ:XBIT) Weighed On By Its Debt Load? - Simply Wall St
Hidradenitis Suppurativa Market Demand, Share, Size, Trends, Forecast To 2033 - WhaTech
Cancer Cachexia Market Forecasted to Reach $3.14 Billion by 2028 with a CAGR of 6.2% - GlobeNewswire Inc.
XBiotech Inc. (NASDAQ:XBIT) Stock Holdings Increased by Vanguard Group Inc. - Defense World
XBiotech (NASDAQ:XBIT) Stock Crosses Above Fifty Day Moving Average of $6.22 - MarketBeat
XBiotech (NASDAQ:XBIT) Shares Pass Above 50 Day Moving Average of $6.22 - Defense World
XBiotech: Q2 Earnings Snapshot - CT Insider
XBIT Stock Earnings: XBiotech Reported Results for Q2 2024 - InvestorPlace
(XBIT) Trading Signals - Stock Traders Daily
XBiotech (NASDAQ:XBIT) Stock Crosses Above 50 Day Moving Average of $6.35 - Defense World
XBiotech Inc. (NASDAQ:XBIT) most popular amongst retail investors who own 51%, insiders hold 35% - Yahoo Finance
XBiotech (NASDAQ:XBIT) Stock Crosses Above 50-Day Moving Average of $6.35 - MarketBeat
(XBIT) Investment Analysis - Stock Traders Daily
XBiotech Inc. (NASDAQ:XBIT) Sees Significant Increase in Short Interest - MarketBeat
XBiotech Inc. (NASDAQ:XBIT) Shares Acquired by Empowered Funds LLC - Defense World
XBiotech Inc. (NASDAQ:XBIT) Sees Large Decrease in Short Interest - Defense World
XBiotech Inc. (NASDAQ:XBIT) Short Interest Update - MarketBeat
Pancreatic Cancer Market to Grow Rapidly by 2034, Predicts - GlobeNewswire
Long Term Trading Analysis for (XBIT) - Stock Traders Daily
XBiotech Inc. (NASDAQ:XBIT) surges 26%; individual investors who own 51% shares profited along with insiders - Simply Wall St
XBiotech (NASDAQ:XBIT) Shares Pass Below 50-Day Moving Average of $7.29 - MarketBeat
XBiotech (NASDAQ:XBIT) Share Price Crosses Below 50 Day Moving Average of $7.29 - Defense World
Xbiotech Inc Stock (XBIT) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.42%
0.16%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):